Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-28 Purchase | 2024-10-30 6:12 pm | Septerna Inc. | SEPN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 4,170,000 | $18 | $75,060,000 | 1,471,943 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-18 6:02 pm | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,833,000 | $18 | $32,994,000 | 2,652,575 (Indirect) | View |
| 2024-07-22 Purchase | 2024-07-24 4:27 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 8,333,333 | $12 | $99,999,996 | 1,288,519 (Indirect) | View |
| 2024-06-27 Purchase | 2024-07-01 9:29 pm | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,008,546 | $3.84 | $49,952,817 | 5,417,638 (Indirect) | View |
| 2023-02-14 Purchase | 2023-02-16 5:04 pm | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,250,000 | $16 | $20,000,000 | 1,311,247 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion